Wafra Inc’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-328,125
Closed -$25.3M 85
2018
Q3
$25.3M Hold
328,125
0.86% 14
2018
Q2
$23.2M Buy
328,125
+117,015
+55% +$8.26M 0.87% 16
2018
Q1
$15.9M Buy
211,110
+94,899
+82% +$7.54M 0.72% 28
2017
Q4
$8.32M Buy
116,211
+4,960
+4% +$377K 0.38% 48
2017
Q3
$9.01M Sell
111,251
-46,204
-29% -$3.53M 0.44% 47
2017
Q2
$11.1M Sell
157,455
-20,791
-12% -$1.38M 0.56% 42
2017
Q1
$12.1M Buy
+178,246
New +$12.5M 0.62% 38
2016
Q3
Sell
-141,310
Closed -$11.8M 80
2016
Q2
$11.8M Buy
141,310
+9,200
+7% +$816K 1.44% 28
2016
Q1
$12.1M Sell
132,110
-16,770
-11% -$1.51M 1.38% 29
2015
Q4
$15.1M Buy
148,880
+3,709
+3% +$386K 1.75% 24
2015
Q3
$14.3M Sell
145,171
-2,746
-2% -$305K 1.75% 23
2015
Q2
$17.3M Sell
147,917
-123,273
-45% -$13.5M 1.88% 25
2015
Q1
$26.6M Hold
271,190
2.79% 5
2014
Q4
$25.6M Buy
271,190
+8,960
+3% +$927K 2.64% 6
2014
Q3
$27.9M Buy
262,230
+14,430
+6% +$1.41M 3.24% 4
2014
Q2
$20.5M Sell
247,800
-13,650
-5% -$1.06M 2.57% 7
2014
Q1
$18.5M Buy
261,450
+18,200
+7% +$1.43M 2.24% 11
2013
Q4
$18.3M Sell
243,250
-26,300
-10% -$1.83M 2.34% 8
2013
Q3
$16.9M Buy
269,550
+17,850
+7% +$1.07M 2.47% 7
2013
Q2
$12.9M Buy
+251,700
New +$13.1M 2.05% 17

Other funds holding GILD

Wafra Inc's GILD Position: Q4 2018 in Review

Wafra Inc sold out of Gilead Sciences (GILD) in Q4 2018, closing a stake of 328,125 shares — an estimated $25.3M sold.

Wafra Inc first reported a position in GILD in Q2 2013 and held it in 20 quarters. The position peaked at $27.9M in Q3 2014. 1,497 funds tracked by Wall St. Rank hold GILD as of Q4 2018.

  • Wafra Inc reported no remaining Gilead Sciences position as of Q4 2018 after selling out during the quarter.
  • Wafra Inc sold 328,125 Gilead Sciences shares in Q4 2018, an estimated $25.3M.
  • Wafra Inc first reported a position in Gilead Sciences in Q2 2013 and held it in 20 quarters.
  • Wafra Inc's Gilead Sciences position peaked at $27.9M in Q3 2014.
  • 1,497 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2018.

Based on Wafra Inc's 13F filing for Q4 2018, filed 13 Feb 2019.